Manami Imai

HEC-1 cells

HEC-1 cell line was the first in vitro cell line of a human endometrial adenocarcinoma which enabled us to perform research work on the endometrium and endometrial carcinoma at a simplified cellular system, contributing cell and molecular biological studies on endometrial carcinoma Once a cell line is established, it provides a stable experimental system that facilitates and progresses in the study of the tissues and/or neoplasias from which they are derived. In this article we report how HEC-1 cells have been established and cleared the proposed requirements to characterize the established cell line. Also to show the usefulness of the cell line for research work, once it was established, we illustrate these concepts by recalling results obtained with HEC-1 cells and reviewing the literature on what has been achieved by using these cells.

HEC-1 Cells: Establishment of an In Vitro Experimental System in Endometrial Carcinoma

The HEC-1 cell line was the first in vitro cell line of a human endometrial adenocarcinoma, which enabled us to perform research work on the endometrium and endometrial carcinoma at the level of a simplified cellular system; contributing to cell and molecular biological studies on endometrial carcinoma. Once a cell line is established, it provides a stable experimental system that facilitates and progresses the study of the tissues and/or neoplasias from which the cell line is derived. In this article, we report how HEC-1 cells have been established and cleared the proposed requirements to characterize an established cell line. In addition, in order to demonstrate the usefulness of the cell lines for research work once they have been established, we illustrate these concepts by recalling results obtained with HEC-1 and the HEC family of endometrial carcinoma cells and review the literature with regard to what has been achieved by using these cells.

Feasibility study of paclitaxel plus carboplatin in patients with endometrial cancer: A Japan Kanto Tumor Board study (JKTB trial)

Aim:  The optimal chemotherapy regimen for patients with endometrial cancer has not been established. We assessed the feasibility of paclitaxel plus carboplatin (TC) for postoperative chemotherapy in patients with endometrial cancer.

Coexisting clear cell adenocarcinoma and squamous cell carcinoma arising from ovarian endometriosis

Abstract A case of clear cell adenocarcinoma and squamous cell carcinoma coexisting in the ovary is presented. These two malignancies were adjacent but were not admixed, and ovarian endometriosis was confirmed concurrently. The clear cell adenocarcinoma was contiguous to monolayered glandular cells with cytological and architectural atypia, while squamous metaplasia with cellular atypia was observed adjacent to the squamous cell carcinoma. We concluded that these two malignancies arose independently from ovarian endometriosis. To our knowledge, this is the first report of such a case.